SCHEMBL2194583

SCHEMBL2194583

IN(I)Cc1ccccc1.[Pt]=c1n(C2CCCCC2)ccn1C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PC1 P35575 1/20 0.38
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
CDK1 P06493 2/20 0.36
PDE9A O76083 2/20 0.36
HSD11B1 P28845 1/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SLC18A3 Q16572 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
KDM4E B2RXH2 3/20 0.34
GAA P10253 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
AGER Q15109 2/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196394 0.91 PDE9A (0.35) G6PC1DRD2DRD4DRD3CDK1
SCHEMBL2198390 0.86 KMT2A (0.39) ALDH1A1KMT2AKDM4E
SCHEMBL2194631 0.86 MEN1 (0.33) MEN1KMT2A
SCHEMBL2198425 0.86 POLB (0.43) ALDH1A1MEN1KMT2AHTTNPSR1
SCHEMBL2193529 0.86 CYP3A4 (0.41) HSD11B1ALDH1A1KDM4EGAAAGER
SCHEMBL2199216 0.83 HRH3 (0.36) DRD2DRD4DRD3ALDH1A1MEN1
SCHEMBL2196361 0.83 HSD11B1 (0.40) PDE9AHSD11B1ALDH1A1KDM4E
SCHEMBL2195565 0.81 SLC18A3 (0.36) G6PC1CDK1PDE9AHSD11B1ALDH1A1
SCHEMBL2195009 0.80 ALDH1A1 (0.31) ALDH1A1KDM4EHTT
SCHEMBL2194945 0.79 KMT2A (0.36) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980875-B2 Platinum-N-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2015-03-17 US claimed
US-20130338128-A1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-12-19 US claimed
US-8481522-B2 Platinum-N-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2013-07-09 US claimed
US-20110172199-A1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-07-14 US claimed
US-20110172199-A1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338128-A1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SCO2, C3AR1, IDH1 G6PC1 4319/4885DRD2 504/4885DRD4 434/4885
US-20110172199-A1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SCO2, C3AR1, IDH1 G6PC1 4319/4885DRD2 504/4885DRD4 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.